Russia IVF (in-vitro fertilization) Market Research Report, 2029

In vitro fertilisation (IVF) has become a major industry in Russia, which over the past several decades has seen a considerable change in the country's healthcare scene. The nation's progress in this area is a result of a combination of advancing technology, changing legal frameworks, and shifting public perceptions on reproductive treatments. Over the past few years, IVF services have been more widely available and accessible throughout Russia's large territory. Numerous causes, such as rising incidence of infertility, increased public knowledge of reproductive health issues, and government initiatives to upgrade healthcare infrastructure, can be credited for this expansion. Due to this, a large number of fertility clinics and specialised clinics have sprung up in well-known cities like Moscow, St. Petersburg, and Novosibirsk, serving the various requirements of couples dealing with infertility. The use of cutting-edge reproductive technology and procedures is one of the main factors propelling Russia's rapidly expanding IVF industry. Modern methods including intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and cryopreservation have been adopted by Russian fertility clinics, providing patients with a broad range of treatment alternatives catered to their individual circumstances. These developments have helped to reduce the hazards connected with reproductive treatments while also improving the success rates of IVF operations. In recent years, Russia's framework for regulating assisted reproductive technologies (ART) has been significantly improved, guaranteeing ethical and high-quality procedures in the IVF industry. Comprehensive laws that have been passed have given IVF treatments a legal foundation, along with regulations pertaining to surrogacy, egg donation, and embryo screening. The rights of patients and donors have been protected thanks to these regulations, which have also promoted responsibility and confidence in the reproductive sector. Although Russia has achieved great strides in the field of IVF, there are still issues and debates related to reproductive health. Topics including the commercialization of reproductive services, differences in treatment accessibility between socioeconomic groups, and moral conundrums surrounding surrogacy persist in igniting discussions in the medical community and the general public. Legislators, medical experts, and the general public must work together to address these issues in order to guarantee fair and moral procedures while providing IVF treatments. According to the research report "Russia Infertility Treatment Market Market Research Report, 2029," published by Actual Market Research, the Russia Infertility Treatment Market market is expected to reach a market size of more than USD 1 Billion by 2029. In vitro fertilisation (IVF) is a field that has grown and advanced significantly in Russia in the last few years. Notable breakthroughs in reproductive technology, greater accessibility to fertility treatments, and the spread of IVF facilities around large cities are among the key developments. Government programmes designed to aid with assisted reproduction have also been instrumental in promoting the expansion of the IVF industry. Research and medical procedure developments have also increased success rates and expanded the range of reproductive treatments that couples can choose from. Because of this, the IVF industry in Russia is growing and providing individuals and couples who are having trouble conceiving with hope and options.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The world of in vitro fertilisation (IVF) cycles is broad in Russia, with a range of alternatives available to suit individual needs. The Fresh Non-donor IVF Cycle is one of the most popular options among them. In this cycle, the prospective mother's eggs are collected, and then sperm fertilisation takes place in a lab. The woman's uterus receives the resultant embryos after that. This method is preferred since it is quick and uses freshly collected eggs, which may increase the success rate. But in Russia, the Frozen Non-donor IVF Cycle is becoming increasingly popular and setting the standard for IVF procedures. Embryos produced from a prior IVF cycle or from donated eggs and sperm are frozen using this technique. Better timing and more flexibility in the treatment procedure are made possible by the ability to keep the frozen embryos for later use. Because of its simplicity, lower cost when compared to new cycles, and similar success rates, this method is gaining traction. Concurrently, there is a surge in the IVF cycle using frozen donors in Russia. Frozen embryos made from donated eggs and sperm are used in this cycle. The donors' gametes are subjected to stringent screening procedures to guarantee their purity and appropriateness. For people or couples who are having trouble conceiving and might benefit from utilising donor gametes, this option offers hope and the opportunity to use in vitro fertilisation (IVF) to start a family. Although they are accessible and used in Russia, fresh donor IVF cycles are not as common as their frozen equivalents. Through the utilisation of recently given eggs and sperm, these cycles give needy individuals or couples instant access to donor gametes. Its relative lack of popularity, meanwhile, could be attributed to logistical difficulties and the requirement for coordination between donors and receivers. In vitro fertilisation, or conventional IVF, has been a trailblazing technique in assisted reproductive technologies in Russia. Using this method, an egg is fertilised with sperm outside the body in a lab dish, and the resultant embryo or embryos are then placed into the uterus. Although traditional IVF is still used extensively in Russia, advances in assisted reproductive technology have partly reduced its appeal in comparison to other techniques. IVF with ICSI is at the forefront of assisted reproductive technologies in Russia (Intracytoplasmic Sperm Injection). With this technique, fertilisation is facilitated by directly inserting a single sperm into an egg. Because IVF with ICSI works well in situations of male infertility, when the sperm may have trouble piercing the egg on its own, it has become quite popular in Russia. Due to its accurate method, it has been the go-to option for couples with male factor infertility, setting the national standard for assisted reproduction. IVF with donor eggs is one of the most used IVF methods in Russia. With this technique, IVF treatments are combined with the eggs of a donor—typically, a young, healthy woman. It offers a workable answer to women who, for a variety of reasons, including old maternal age or ovarian malfunction, are unable to generate healthy eggs on their own. IVF with donor eggs has become a popular option for couples with poor quality eggs, greatly altering the landscape of assisted reproduction in Russia. Russia investigates alternate options in assisted reproductive technologies in addition to standard ones. These might involve methods like cryopreservation of embryos, preimplantation genetic testing, or even experimental processes carried out in reproductive clinics with specialised equipment. These techniques demonstrate the dynamic nature of reproductive medicine in Russia, where continued research and innovation are reshaping the landscape of assisted reproduction even if they may not yet be as common as traditional IVF or IVF with ICSI. In Russia, fertility clinics are essential to solving the country's demographic issues. Due to the dropping birth rate, these clinics are essential resource centres for infertile couples. They provide hope to people looking to establish or grow their family by offering a variety of assisted reproductive technologies (ART), such as intrauterine insemination (IUI) and in vitro fertilisation (IVF). Furthermore, these clinics frequently combine individualised treatment with state-of-the-art medical developments, meeting the particular requirements of Russian couples. As the backbone of Russia's healthcare system, hospitals and surgical centres provide a comprehensive range of medical services, including specialised treatments for infertility. These facilities offer a multidisciplinary approach to reproductive treatment, with knowledgeable medical specialists working together from a range of specialisations, including genetics, endocrinology, and gynaecology. These centres prioritise patient safety and well-being while providing complete pre- and post-operative care, in addition to fertility therapies. In Russia, cryobanks are essential for conserving reproductive organs and cells for later use. These facilities let people and couples to retain their potential for reproduction by storing sperm, eggs, and embryos. These cryobanks guarantee the long-term survival of stored reproductive material thanks to developments in cryopreservation technology, giving patients undergoing medical procedures that may damage their fertility a sense of security and autonomy. Moreover, these institutions follow strict legal guidelines to protect the confidentiality and integrity of stored specimens. Russia's research institutions provide a substantial contribution to the advancement of reproductive medical science. These institutions do ground-breaking research to enhance fertility therapies, identify the root causes of infertility, and create cutting-edge assisted reproductive technologies. Russian research institutions participate in clinical trials and collaborate with foreign partners to solve issues related to infertility and reproductive health globally. These institutions also act as centres of education, educating the next wave of scientists and fertility experts who will lead the field's achievements in the future.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Kripa Shah

Senior Analyst

Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • IVF market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By cycle • Fresh Non-donor IVF Cycle • Frozen Non-donor IVF Cycle • Frozen donor IVF Cycle • Fresh donor IVF Cycle By Conventional IVF • Conventional IVF • IVF with ICSI (Instracytoplasmic Sperm Injection) • IVF With Donor Eggs • other By End user • Fertility Clinics • Hospital & Surgical Centers • Cryobanks • Research institute The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.